Washington, DC Hosting Bird Flu Summit for Businesses
Business leaders will have access to bird flu experts from around the world to address pandemic prevention, preparedness, response and recovery February 27-28, 2006, at Washington, DC's first Bird Flu Summit.
Washington, DC (PRWEB) February 7, 2006 -- Bird flu experts will focus on the business-related issues in pandemic prevention, preparedness, response and recovery at Washington, DC's first Bird Flu Summit to be held February 27-28, 2006 at the Hyatt Regency Crystal City near Reagan National Airport.
The 2-day event, featuring public sector and private sector leaders addressing the bird flu threat, will be co-chaired by international healthcare advisor Dr. Joseph Agris (www.flulab.com), and will present collective approaches to pandemic influenza preparedness and business continuity planning.
Special emphasis will be placed on identifying the responsibilities of various stakeholders in order to improve communications, coordination and collaboration worldwide.
Dr. Agris will also outline proposed measures for Iraq, where bird flu deaths have been recently reported.
Confirmed speakers and topics include:
Overview
Koos van der Velden
Chairman
European Influenza Surveillance Scheme
Country Report and Situation Updates
Dr. Huseyin Avni Sahin
Chief Physician
Van Yuzuncu Yil Research Hopital, Turkey
Dr. Mircea Ioan Popa
Associate Professor in Microbiology
Adviser to the Minister of Health
Ministry of Health, Romania
Avian influenza: Animals, Man and Pathogen
Alex Thiermann
President
Terrestrial Animal Health Code Commission
World Organization for Animal Health ( OIE )
Bird Flu Transmission to Humans May Be Higher Than Thought
Anna Thorson, M.D., Ph.D
Researcher
Division of International Health
Department of Public Health Sciences
Karolinska Institute, Stockholm, Sweden.
The Epidemiology and Evolution of Human and Animal Influenza Viruses
Dr. Alan J. Hay
Director, World Influenza Centre
National Institute for Medical Research, London
Surveillance and Data Management
Michael Wagner, M.D., Ph.D.
Director
Real-time Outbreak and Disease Surveillance ( RODS ) Laboratory
Veronica Urdaneta
State Epidemiologist and Division Director,
Bureau of Epidemiology
Pennsylvania Department of Health
Marion A. Kainer MD, MPH, FRACP
Medical Epidemiologist
Communicable and Environmental Disease Services
Tennessee Deptartment of Health
Dr. Patricia Somsel
Director
Division of Infectious Disease, Bureau of Laboratories
Michigan Department of Community Health
Dr. Andrew Miller
Syndrome Reporting Information System ( SYRIS ) Product Manager
ARES Corporation
Preparing Communities Strategies; Local Partnership and Participation
Tim Stephens
President
Rescobie Associates, Inc.
Sheriff James Hagy
Office of Sheriff
Law Enforcement Center
Frederick, MD
John Thompson
Deputy Executive Director
National Sheriffs Association
Critical Infrastructure Continuity
Dr. Tom McGinn
Sector Specialist
Public Health, Food and Agriculture
Department of Homeland Security
Vaccine Delivery
John Iskander
Project officer
Vaccine Adverse Events Reporting System
CDC
Dr. Andrea Gambotto
Asst. Professor of Surgery
Co-director, Vector Core Facility
University of Pittsburgh School of Medicine
The Aethlon Hemopurifier as a Treatment for Drug Resistant Avian Flu
James A. Joyce
Chairman, CEO
Aethlon Medical, Inc.
Emergency Response and Hospital/Health Care Coordination
John O. Davies-Cole
State Epidemiologist
Washington DC Department of Health
Dr. Sandra Schneider
Professor and Chair
University of Rochester
Playing Ostrich or Talking Turkey: Pre-Pandemic Risk Communication Strategies
Jody Lanard M.D.
Risk Communication Specialist
Princeton, NJ
The Peter Sandman Risk Communication
Poultry Farms: The Frontline Fight Against Avian Flu
Dr. Bruce N. Stewart-Brown
Vice President
Food Safety and Quality
Perdue Farms
Dr. Steve Roney
Director
Veterinary Services
Gold Kist Inc.
Benefit-Risk Assessment: Public Health, Industry and Regulatory Perspectives
Brian T. Yeh
Legislative Attorney
American Law Division
Congressional Research Service
Doug Colwell
Director of Immunobiology
Antigen Express, Inc. ( Generex )
Stephen Aldrich
CEO
Bio Economic Research Associates (BIO-ERA)
The Effect of a Bird Flu Pandemic on the U.S. Life Insurance Industry
Dr. Steven Weisbart
Economist
Insurance Information Institute
Prevention Education Efforts and Risk Communication
Caroline Smith DeWaal
Director for Food Safety
Center for Science in the Public Interest
Antiviral Agents
C. Shane Arnold, Ph.D.
Director, Peramivir Development
Research Biologist II
BioCryst Pharmaceuticals, Inc.
Legal Considerations: Immunizing Vaccine Manufacturers
Jason Waite
Partner
Alston and Bird
Christopher Milne
Assistant Director
Tufts Center for the Study of Drug Development
John Clerici
Partner
Mckenna Long Aldridge
Prospective speakers and attendees may register by calling the conference organizer, NewFields/USA, at 1-202-536-5000 or visiting www.new-fields.com/birdflu.
# # #
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/WmV0YS1Ib3JyLVN1bW0tUGlnZy1IYWxmLVplcm8=
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
